SENS Research Foundation

Last updated
SENS Research Foundation
FoundedMarch 2009;14 years ago (2009-03)
Founder Aubrey de Grey, Jeff Hall, Michael Kope, Sarah Marr, Kevin Perrott
Type 501(c)(3)
Focus Rejuvenation
Location
Area served
Global
Method SENS
Key people
Lisa Fabiny-Kiser (CEO) [1] Bill Liao (Chairman), Maria Entraigues-Abramson , Kevin Dewalt, Jeff Hall, Michael Kope, Barbara J. Logan, Kevin Perrott
Website www.sens.org

The SENS Research Foundation is a non-profit organization that does research programs and public relations work for the application of regenerative medicine to aging. It was founded in 2009, located in Mountain View, California, USA. The organization publishes its reports annually. [2] [3] [4] [5]

Contents

History

Before the foundation was founded in March 2009, the SENS research program was mainly pursued by the Methuselah Foundation, co-founded by Aubrey de Grey and David Gobel.

When the SENS rejuvenation approach was announced in the 2000s, while some biogerontologists supported the SENS program, many contended that the ultimate goals of de Grey's programme were too speculative given the state of technology and referred to it as "fantasy rather than science". [6] [7] By the mid-2010s, the rejuvenation approach gained traction with multiple startup companies created from SENS research findings. In 2021 Michael Greve pledged another €300 million for rejuvenation biotechnology startup companies. [8] [9] In 2021, Underdog Pharmaceuticals, a startup company spun out from a research program at SENS Research Foundation, was awarded an Innovation Passport from the United Kingdom Medicines and Healthcare products Regulatory Agency, which intends to streamline the approval program of promising therapies. [10] In August 2021, Aubrey de Grey was suspended from the foundation. [11] The CEO of the SENS Research Foundation, Jim O’Neill left in the preceding July, at the same time de Grey was suspended. [11]

Goals

According to the organization site, its goal is to "help build the industry that will cure the diseases of aging". It funds research and uses outreach and education in order to expedite the various regenerative medicine research programs that go together to make the SENS project. The foundation also conducts its own student program SRF Education. [12]

Research

Research programs

The SENS Research Foundation (SRF) pursues research projects that correspond to the seven categories of cellular damage due to aging:

Aging damageResearch programDescription and related spin-off companies
Cell loss and cell atrophy RepleniSENS
Division-obsessed cellsOncoSENS
  • OncoSENS's solution is to preemptively remove the genes for the telomere-lengthening machinery.
  • OncoSenX's (spinout from Oisin Biotechnologies, which is a SENS seed-funded startup) [15] suicide gene therapy results in 75-90% reduction in tumor in mice. [16] [17]
Death-resistant cellsApoptoSENS
  • Oisin Biotechnologies (SENS seed-funded startup) has a precise targeting technology, which is based on senescent cells' DNA expression. [15]
Mitochondrial mutationsMitoSENS
  • Allotopic expression of 13 proteins [18]
  • Initial proof of concept using ATP8 and ATP6 genes was successful. Research was published in the peer-reviewed Nucleic Acids Research journal. [19]
  • The mitochondrial transplantation project aims to take advantage of the body's natural process of mitochondrial exchange for healthy mitochondrial transfusion. [20]
Intracellular waste productsLysoSENS
  • Ichor Therapeutics is developing repair therapy for macular degeneration. [21]
  • Underdog Pharmaceuticals received an Innovation Passport, an accelerated regulatory pathway from the UK government for promising therapies, for a small molecule drug to treat atherosclerosis by clearing arterial plaques. [22] Underdog and SRF received a grant from the National Institutes of Health to pursue this research further. [23]
Extracellular waste productsAmyloSENS
  • The Degradation of Tau Aggregates project seeks to remove aggregated tau proteins, which are part of age-related cognitive decline, Alzheimer's, and other tauopathies. [24]
Extracellular matrix stiffeningGlycoSENS

Research collaboration

In addition to research undertaken in-house at the Research Center in Mountain View, SRF has also taken part in and/or selectively funded extramural research at various other institutions, including Yale University, Harvard University, Cambridge University, University of Texas, Rice University, and University of Arizona. [2]

Research advisory board

The SENS Research Foundation's research advisory board includes Pedro J. J. Alvarez, Anthony Atala, George Church, Judith Campisi, William A. Haseltine, Brian K. Kennedy, Jeanne Loring, María Blasco Marhuenda, Bruce Rittmann, Nadia Rosenthal, Rudolph E. Tanzi, Jan Vijg, Michael D. West, and Vladimir Skulachev. [26]

Funding source


SRF funding in 2021 [27]

Owing to the close relationship between SENS Foundation and Methuselah Foundation and their common activities, during reading articles and public reports there are sometimes misunderstanding about their budgets, directions and amounts of donations which can be distributed between these organizations for various purposes.

On December 9, 2010, Jason Hope, an entrepreneur based in Scottsdale, AZ, pledged a $500,000 donation. [28]

In 2011, Aubrey de Grey inherited $16.5 million on the death of his mother. Of this he assigned $13 million to fund SENS research, which by 2013 had the effect of roughly doubling the SRF yearly budget to $4 million. [29]

According SRF annual reports,

The Pineapple Fund donated $2 million to SENS in 2017–18, [30] [31] that's in addition to $1 million donated to Methuselah Foundation. [32]

Ethereum co-founder Vitalik Buterin donated $2.4 million in 2018. [3] [33] [34] [35] Then in 2020 Vitalik Buterin together with Sam Bankman-Fried and Haseeb Qureshi donated a total of $150,000 to SENS Research Foundation to combat aging and aging-related diseases at the choice of users of Twitter as a result of open voting. [36]

In 2020, Oculus cofounder Michael Antonov donated $1 million, of which $600,000 was a matching donation. [37] [38]

See also

Related Research Articles

The Machine Intelligence Research Institute (MIRI), formerly the Singularity Institute for Artificial Intelligence (SIAI), is a non-profit research institute focused since 2005 on identifying and managing potential existential risks from artificial general intelligence. MIRI's work has focused on a friendly AI approach to system design and on predicting the rate of technology development.

<span class="mw-page-title-main">Aubrey de Grey</span> English author and biogerontologist

Aubrey David Nicholas Jasper de Grey is an English author and biomedical gerontologist. He is the author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging (2007). He is known for his view that medical technology may enable human beings alive today not to die from age-related causes. As an amateur mathematician, he has contributed to the study of the Hadwiger–Nelson problem in geometric graph theory, making the first progress on the problem in over 60 years.

Strategies for engineered negligible senescence (SENS) is a range of proposed regenerative medical therapies, either planned or currently in development, for the periodic repair of all age-related damage to human tissue. These therapies have the ultimate aim of maintaining a state of negligible senescence in patients and postponing age-associated disease. SENS was first defined by British biogerontologist Aubrey de Grey. Many mainstream scientists believe that it is a fringe theory.

The following outline is provided as an overview of and topical guide to life extension:

<span class="mw-page-title-main">Methuselah Foundation</span> U.S. nonprofit organization

The Methuselah Foundation is an American-based global non-profit organization based in Springfield, Virginia, with a declared mission to "make 90 the new 50 by 2030" by supporting tissue engineering and regenerative medicine therapies. The organization was originally incorporated by David Gobel in 2001 as the Performance Prize Society, a name inspired by the British governments Longitude Act, which offered monetary rewards for anyone who could devise a portable, practical solution for determining a ship's longitude.

<span class="mw-page-title-main">David Gobel</span> American philanthropist, entrepreneur, inventor and futurist

David Gobel is an American philanthropist, entrepreneur, inventor, and futurist. He is co-founder and CEO of the Methuselah Foundation, CEO of the Methuselah Fund, and one of the first to publicly advance the idea of longevity escape velocity, even before this term was formulated.

<i>Ending Aging</i> 2007 book by Aubrey de Grey and Michael Rae

Ending Aging: The Rejuvenation Breakthroughs that Could Reverse Human Aging in Our Lifetime is a 2007 book written by biogerontologist Aubrey de Grey, with his research assistant Michael Rae. Ending Aging describes de Grey's proposal for eliminating aging as a cause of debilitation and death in humans, and restoring the body to an indefinitely youthful state, a project that he calls the "strategies for engineered negligible senescence" ("SENS"). De Grey argues that defeating aging is feasible, possibly within a few decades, and he outlines steps that can be taken to hasten the development of regenerative medicine treatments for each side of aging.

The Thiel Fellowship is a fellowship created by billionaire Peter Thiel through the Thiel Foundation. The fellowship is intended for students aged 22 or younger and offers them a total of $100,000 over two years, as well as guidance and other resources, to drop out of school and pursue other work, which could involve scientific research, creating a startup, or working on a social movement. Selection for the fellowship is through a competitive annual process, with about 20–25 fellows selected annually.

The Thiel Foundation is a private foundation created and funded by billionaire Peter Thiel, co-founder of PayPal and an early investor in Facebook.

<span class="mw-page-title-main">Vitalik Buterin</span> Russian-Canadian programmer (born 1994)

Vitaly Dmitrievich Buterin, better known as Vitalik Buterin, is a Russian-Canadian computer programmer, and co-founder of Ethereum. Buterin became involved with cryptocurrency early in its inception, co-founding Bitcoin Magazine in 2011. In 2014, Buterin deployed the Ethereum blockchain with Gavin Wood, Charles Hoskinson, Anthony Di Iorio, and Joseph Lubin.

<span class="mw-page-title-main">Ethereum</span> Open-source blockchain computing platform

Ethereum is a decentralized blockchain with smart contract functionality. Ether is the native cryptocurrency of the platform. Among cryptocurrencies, ether is second only to bitcoin in market capitalization. It is open-source software.

Bitcoin Magazine is one of the original news and print magazine publishers covering Bitcoin and digital currencies. Bitcoin Magazine began publishing in 2012. It was co-founded by Vitalik Buterin, Mihai Alisie, Matthew N. Wright, Vladimir Marchenko, and Vicente S. It is currently owned and operated by BTC Inc in Nashville, Tennessee.

<span class="mw-page-title-main">Cardano (blockchain platform)</span> Public blockchain platform

Cardano is a public blockchain platform. It is open-source and decentralized, with consensus achieved using proof of stake. It can facilitate peer-to-peer transactions with its internal cryptocurrency, ADA.

<span class="mw-page-title-main">Abra (company)</span> Financial services and technology company

Abra is a financial services and technology company that operates a cryptocurrency wallet service including a trading service for buying and selling cryptocurrencies, a service for earning interest on cryptocurrencies and stablecoins, and a lending services for borrowing against cryptocurrency collateral.

<span class="mw-page-title-main">Gavin Wood</span> British computer programmer and entrepreneur

Gavin James Wood is an English computer scientist, a co-founder of Ethereum and creator of Polkadot and Kusama.

The Pineapple Fund was a philanthropic project by an anonymous individual which gave away 5,057 bitcoins to 60 charities. The amount was valued at $86 million in December 2017. Some of the themes supported were medical research, environmental conservation, human rights and psychedelic therapy.

<span class="mw-page-title-main">Charles Hoskinson</span> American cryptocurrency entrepreneur

Charles Hoskinson is an American entrepreneur who is a co-founder of the blockchain engineering company Input Output Global, Inc., and the Cardano blockchain platform, and was a co-founder of the Ethereum blockchain platform.

<span class="mw-page-title-main">Hack Club</span>

Hack Club is a global nonprofit network of high school computer hackers, makers and coders founded in 2014 by Zach Latta. It now includes more than 400 high school clubs and 27,500 students. It has been featured on the TODAY Show, and profiled in the Wall Street Journal and many other publications.

The COVID-Crypto Relief Fund was announced on 24 April 2021 during the second wave of the COVID-19 pandemic in India. India Crypto Relief Fund was founded by Sandeep Nailwal.

StarkWare Industries is an Israeli software company that specializes in cryptography. It develops zero-knowledge proof technology that compresses information to address the scalability problem of the blockchain, and works on the Ethereum platform. In May 2022, the company's estimated value was $8 billion, an increase from $2 billion six months earlier.

References

  1. Zhavoronkov, Alex (April 17, 2023). "Women In Longevity And The Renaissance Of The SENS Research Foundation". Forbes .
  2. 1 2 "SENS Research Foundation 2011 Annual Report" (PDF).
  3. 1 2 3 "SENS Research Foundation 2018 Annual Report" (PDF).
  4. 1 2 "SENS Research Foundation 2019 Annual Report" (PDF).
  5. 1 2 "SENS Research Foundation 2020 Annual Report" (PDF).
  6. Warner H; Anderson J; Austad S; et al. (November 2005). "Science fact and the SENS agenda. What can we reasonably expect from ageing research?". EMBO Reports. 6 (11): 1006–8. doi:10.1038/sj.embor.7400555. PMC   1371037 . PMID   16264422.
  7. Holliday R (April 2009). "The extreme arrogance of anti-aging medicine". Biogerontology. 10 (2): 223–8. doi:10.1007/s10522-008-9170-6. PMID   18726707. S2CID   764136.
  8. Michael Greve Announces a New €300 Million Fund for Investment in Rejuvenation Biotechnology Startups
  9. Michael Greve, founder of Forever Healthy, commits €300 million to advance rejuvenation startups
  10. "Kizoo portfolio company Underdog awarded 'Innovation Passport' by UK Regulators". 8 September 2021. Archived from the original on 2021-09-08.
  11. 1 2 "Anti-aging foundation's CEO left amid probe of Aubrey de Grey". STAT. 2021-08-13. Retrieved 2021-08-15.
  12. "About SENS Research Foundation". Official SENS site. Retrieved 2021-03-26.
  13. "RepleniSENS:Replacing Lost Cells". SENS Research Foundation. Retrieved 2020-12-31.
  14. "Functional Neuron Replacement to Rejuvenate the Neocortex". 25 March 2019.
  15. 1 2 "Plasmid based senolytics from Oisín Biotechnologies". Lifespan.io. Retrieved 2021-04-07.
  16. "Systemic Senolysis in Naturally Aged Mice". YouTube. Archived from the original on 2021-01-18. Retrieved 2021-01-09.
  17. Dr. John Lewis (2018-10-11). "Selective Ablation of Senescent and Malignant Cells using Apoptotic Gene Therapy" (lecture). University of Alberta.
  18. "MitoSENS: Preventing Damage from Mitochondrial Mutations". SENS Research Foundation. Retrieved 2020-12-31.
  19. Boominathan, Amutha; et al. (2016-09-04). "Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutant". Nucleic Acids Research. 44 (19): 9342–9357. doi: 10.1093/nar/gkw756 . PMC   5100594 . PMID   27596602.
  20. "Engineering New Mitochondrial Genes to Restore Mitochondrial Function (MitoSENS)". 15 June 2021.
  21. "Fight Aging! Invests in Ichor Therapeutics to Support Development of a SENS Damage Repair Therapy for Macular Degeneration". Fight Aging!. 2016-08-15.
  22. "Kizoo portfolio company Underdog awarded 'Innovation Passport' by UK Regulators". 8 September 2021. Archived from the original on 2021-09-08.
  23. "SENS Research Foundation & Underdog Pharmaceuticals jointly awarded $252,000 NIA research grant". 9 December 2021.
  24. "Catalyzing Degradation of Tau Aggregates". 16 June 2021.
  25. "Revel Pharmaceuticals Finally Seed Funded to Develop Glucosepane Cross-Link Breakers". Fight Aging!. 2020-01-07.
  26. SENS Research Foundation Research Advisory Board
  27. "SENS Research Foundation 2022 Annual Report" (PDF).
  28. "Internet Entrepreneur Jason Hope Pledges A Donation To SENS Foundation". December 9, 2010. Retrieved 2021-03-29.
  29. Ben Best (2013) "Interview with Aubrey de Grey, PhD". Life Extension Magazine.
  30. Bitcoin Transaction 10dd3b4bb1…
  31. Bitcoin Transaction f0aa1cc5bc…
  32. "The Pineapple Fund Donates Millions to the Organ Preservation Alliance and Methuselah Foundation". Fight Aging!. 2018-01-29.
  33. "SENS Research Foundation Receives $2.4 Million Ethereum Donation From Vitalik Buterin" (Press release). SENS Research Foundation. 2018-02-02.
  34. Elena, Milova (March 20, 2018). "Vitalik Buterin: The Best Thing to Donate Money to is The Fight Against Aging". LIFE EXTENSION ADVOCACY FOUNDATION. Archived from the original on 2018-03-22. Retrieved March 21, 2018.
  35. Анна ДОБРЮХА (2018-03-20). ""Король Эфириума" Виталик Бутерин: лучшее, на что стоит жертвовать деньги — это борьба со старением" [«King of Ethereum» Vitalik Buterin: the best thing to donate money for is the fight against aging] (in Russian). Komsomolskaya Pravda.
  36. "Effective Altruism: Giving in Crypto". 2020-12-17.
  37. 2020 End of Year Fundraiser
  38. Michael Antonov Foundation: SENS Research Foundation